{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T10:04:55Z","timestamp":1784714695691,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Young and middle-aged academic and technical leaders in the reserve talent program","award":["202305AC160016"],"award-info":[{"award-number":["202305AC160016"]}]},{"name":"Yunnan Provincial Health Commission High-Level Medical Talent Training Program","award":["NO. L-2025020"],"award-info":[{"award-number":["NO. L-2025020"]}]},{"DOI":"10.13039\/501100019413","name":"Yunnan Provincial Department of Education Science Research Fund Project","doi-asserted-by":"publisher","award":["NO. 2025J0323"],"award-info":[{"award-number":["NO. 2025J0323"]}],"id":[{"id":"10.13039\/501100019413","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The First affiliated hospital of Kunming medical university Doctoral foundation","award":["NO. 2022BS004"],"award-info":[{"award-number":["NO. 2022BS004"]}]},{"name":"State key laboratory of neurology and oncology drug development young program","award":["SKLSIM-F-2024107"],"award-info":[{"award-number":["SKLSIM-F-2024107"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lab Anim Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pigmentary cutaneous disorders are characterized by abnormal decreases or increases in melanin production, leading to altered skin coloration. These conditions include vitiligo, melasma, and post-inflammatory hyperpigmentation. The etiology of these dermatological manifestations is multifactorial, encompassing environmental triggers, hormonal fluctuations, psychological stress, and physical trauma. Although generally non-life-threatening, these disorders significantly impact patients\u2019 quality of life due to visible disfigurement and consequent psychosocial distress. This paper reviews the methods used to establish animal models for different types of pigmentary skin diseases and the research progress in this area. By examining published experimental studies, we have sorted out the modeling methods for these animal models and discussed their potential applications in clinical treatment research. Studies have shown that establishing appropriate animal models is beneficial for understanding the pathogenesis of pigmentary skin diseases and for conducting drug screening and dosage form optimization. Although no major breakthroughs have been made so far, the existing research results have provided an important foundation for future studies and supported the potential of these models in clinical treatment research. Establishing appropriate animal models for pigmentary skin diseases is both feasible and meaningful. With the continuous improvement of modeling techniques and a deeper understanding of the model mechanisms, animal models for pigmentary skin diseases will provide a powerful tool for verifying new treatment methods, thereby promoting progress in clinical treatment.<\/jats:p>","DOI":"10.1186\/s42826-026-00287-5","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T09:38:37Z","timestamp":1784713117000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advances in animal models of pigmentary skin disorders"],"prefix":"10.1186","volume":"42","author":[{"given":"Zhenghong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongliang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5966-3570","authenticated-orcid":false,"given":"Hui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"issue":"12","key":"287_CR1","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.3390\/molecules28124839","volume":"28","author":"AM Thawabteh","year":"2023","unstructured":"Thawabteh AM, Jibreen A, Karaman D, Thawabteh A, Karaman R. Skin Pigmentation Types, Causes and Treatment-A Review. Molecules. 2023;28(12):4839.","journal-title":"Molecules"},{"issue":"1","key":"287_CR2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/jocd.14770","volume":"22","author":"P Karagaiah","year":"2023","unstructured":"Karagaiah P, Schwartz RA, Lotti T, Wollina U, Grabbe S, Goldust M. Biologic and targeted therapeutics in vitiligo. J Cosmet Dermatol. 2023;22(1):64\u201373.","journal-title":"J Cosmet Dermatol"},{"issue":"1","key":"287_CR3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s12016-017-8622-7","volume":"54","author":"K Boniface","year":"2018","unstructured":"Boniface K, Seneschal J, Picardo M, Ta\u00efeb A, Vitiligo. Focus on Clinical Aspects, Immunopathogenesis, and Therapy. Clin Rev Allergy Immunol. 2018;54(1):52\u201367.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"287_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jaut.2003.09.006","volume":"22","author":"X Wang","year":"2004","unstructured":"Wang X, Erf GF. Apoptosis in feathers of Smyth line chickens with autoimmune vitiligo. J Autoimmun. 2004;22(1):21\u201330.","journal-title":"J Autoimmun"},{"key":"287_CR5","doi-asserted-by":"publisher","first-page":"1386727","DOI":"10.3389\/fimmu.2024.1386727","volume":"15","author":"DM Falcon","year":"2024","unstructured":"Falcon DM, Byrne KA, Sales MA, Erf GF. Spontaneous immunological activities in the target tissue of vitiligo-prone Smyth and vitiligo-susceptible Brown lines of chicken. Front Immunol. 2024;15:1386727.","journal-title":"Front Immunol"},{"issue":"10","key":"287_CR6","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1002\/ptr.5161","volume":"28","author":"SX Huo","year":"2014","unstructured":"Huo SX, Liu XM, Ge CH, Gao L, Peng XM, Zhao PP, et al. The effects of galangin on a mouse model of vitiligo induced by hydroquinone. Phytother Res. 2014;28(10):1533\u20138.","journal-title":"Phytother Res"},{"issue":"11","key":"287_CR7","doi-asserted-by":"publisher","first-page":"6270","DOI":"10.1111\/jocd.15233","volume":"21","author":"AHN Ubaydee","year":"2022","unstructured":"Ubaydee AHN, Issa R, Hajleh MNA, Ghanim BY, Al-Akayleh F, Qinna NA. The effect of Medicago sativa extract and light on skin hypopigmentation disorders in C57\/BL6 mice. J Cosmet Dermatol. 2022;21(11):6270\u201380.","journal-title":"J Cosmet Dermatol"},{"issue":"8","key":"287_CR8","doi-asserted-by":"publisher","first-page":"6990","DOI":"10.3390\/ijms24086990","volume":"24","author":"J Dong","year":"2023","unstructured":"Dong J, Lai Y, Zhang X, Yue Y, Zhong H, Shang J. Optimization of Monobenzone-Induced Vitiligo Mouse Model by the Addition of Chronic Stress. Int J Mol Sci. 2023;24(8):6990.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"287_CR9","doi-asserted-by":"publisher","first-page":"135563","DOI":"10.1111\/exd.14603","volume":"31","author":"A Erdo\u011fan","year":"2022","unstructured":"Erdo\u011fan A, Mutlu HS, Solako\u011flu S. Autologously transplanted dermis-derived cells alleviated monobenzone-induced vitiligo in mouse. Exp Dermatol. 2022;31(9):135563.","journal-title":"Exp Dermatol"},{"issue":"1","key":"287_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/cei.12146","volume":"174","author":"S You","year":"2013","unstructured":"You S, Cho YH, Byun JS, Shin EC. Melanocyte-specific CD8+ T cells are associated with epidermal depigmentation in a novel mouse model of vitiligo. Clin Exp Immunol. 2013;174(1):38\u201344.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"287_CR11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.0022-202X.2004.23538.x","volume":"124","author":"J Steitz","year":"2005","unstructured":"Steitz J, Br\u00fcck J, Lenz J, B\u00fcchs S, T\u00fcting T. Peripheral CD8+ T cell tolerance against melanocytic self-antigens in the skin is regulated in two steps by CD4+ T cells and local inflammation: implications for the pathophysiology of vitiligo. J Invest Dermatol. 2005;124(1):144\u201350.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"287_CR12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1084\/jem.185.3.453","volume":"185","author":"MB Bloom","year":"1997","unstructured":"Bloom MB, Perry-Lalley D, Robbins PF, Li Y, el-Gamil M, Rosenberg SA, et al. Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma. J Exp Med. 1997;185(3):453\u20139.","journal-title":"J Exp Med"},{"issue":"1","key":"287_CR13","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s13287-025-04410-6","volume":"16","author":"R Fan","year":"2025","unstructured":"Fan R, Gao J, Chen J. Hair follicle-derived melanocyte transplant as a promising treatment strategy for vitiligo. Stem Cell Res Ther. 2025;16(1):280.","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"287_CR14","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1016\/j.immuni.2025.05.018","volume":"58","author":"X Yang","year":"2025","unstructured":"Yang X, Ding W, Lou F, Xu H, Sheng A, Sun Y, et al. Nociceptor-derived CGRP enhances dermal type I conventional dendritic cell function to drive autoreactive CD8+ T cell responses in vitiligo. Immunity. 2025;58(8):2086\u2013103.","journal-title":"Immunity"},{"key":"287_CR15","doi-asserted-by":"publisher","first-page":"1677626","DOI":"10.3389\/fmed.2025.1677626","volume":"12","author":"Y Xie","year":"2025","unstructured":"Xie Y, Cui J, Lu Y, Du Y, Chang J. The fibroblast-driven melanoma\/Treg vitiligo mouse model is effectively suppressed by IFN\u03b3 blocking antibody. Front Med (Lausanne). 2025;12:1677626.","journal-title":"Front Med (Lausanne)"},{"issue":"Pt 1","key":"287_CR16","doi-asserted-by":"publisher","first-page":"143070","DOI":"10.1016\/j.ijbiomac.2025.143070","volume":"310","author":"J Ma","year":"2025","unstructured":"Ma J, Zhou Y, Chen J, Guo S, Zhang W, Yi X, et al. Exosomes enriched with miR-31-3p from keratinocytes under oxidative stress promote vitiligo progression by destructing melanocytes and activating CD8+ T cells. Int J Biol Macromol. 2025;310(Pt 1):143070.","journal-title":"Int J Biol Macromol"},{"issue":"6","key":"287_CR17","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/exd.13844","volume":"28","author":"SH Kwon","year":"2019","unstructured":"Kwon SH, Na JI, Choi JY, Park KC. Melasma: Updates and perspectives. Exp Dermatol. 2019;28(6):704\u20138.","journal-title":"Exp Dermatol"},{"issue":"11","key":"287_CR18","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1111\/jocd.14382","volume":"20","author":"O Artzi","year":"2021","unstructured":"Artzi O, Horovitz T, Bar-Ilan E, Shehadeh W, Koren A, Zusmanovitch L, et al. The pathogenesis of melasma and implications for treatment. J Cosmet Dermatol. 2021;20(11):3432\u201345.","journal-title":"J Cosmet Dermatol"},{"key":"287_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jep.2018.09.036","volume":"229","author":"JH Han","year":"2019","unstructured":"Han JH, Bang JS, Choi YJ, Choung SY. Anti-melanogenic effects of oyster hydrolysate in UVB-irradiated C57BL\/6J mice and B16F10 melanoma cells via downregulation of cAMP signaling pathway. J Ethnopharmacol. 2019;229:137\u201344.","journal-title":"J Ethnopharmacol"},{"key":"287_CR20","doi-asserted-by":"publisher","first-page":"106664","DOI":"10.1016\/j.ejps.2023.106664","volume":"192","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Zhou L, Tao W, Yang X, Li J, Wang R, et al. Preparation of paeoniflorin-glycyrrhizic acid complex transethosome gel and its preventive and therapeutic effects on melasma. Eur J Pharm Sci. 2024;192:106664.","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"287_CR21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jdermsci.2016.06.007","volume":"84","author":"JW Park","year":"2016","unstructured":"Park JW, Ha YM, Kim DH, Lee B, Lee EK, Chung KW, et al. 4-(6,7-Dihydro-5H-indeno[5,6-d] thiazol-2-yl)benzene-1,3-diol prevents UV-induced melanogenesis and wrinkle formation in HRM-2 hairless mice. J Dermatol Sci. 2016;84(2):213\u20136.","journal-title":"J Dermatol Sci"},{"issue":"5","key":"287_CR22","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1684\/ejd.2023.4586","volume":"33","author":"ZX Liang","year":"2023","unstructured":"Liang ZX, Wang MR, Xiang XJ, Zhao Y. Treatment with injectable platelet-rich fibrin in a rat model of melasma. Eur J Dermatol. 2023;33(5):487\u201394.","journal-title":"Eur J Dermatol"},{"key":"287_CR23","doi-asserted-by":"publisher","first-page":"118388","DOI":"10.1016\/j.jep.2024.118388","volume":"332","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Tao W, Shan X, Li D, Tao W, Qian H, et al. Components analysis of San-Bai decoction, and its pharmacodynamics and mechanism on preventing and treating melasma. J Ethnopharmacol. 2024;332:118388.","journal-title":"J Ethnopharmacol"},{"key":"287_CR24","doi-asserted-by":"publisher","first-page":"120406","DOI":"10.1016\/j.ijpharm.2021.120406","volume":"600","author":"M Xing","year":"2021","unstructured":"Xing M, Wang X, Zhao L, Zhou Z, Liu H, Wang B, et al. Novel dissolving microneedles preparation for synergistic melasma therapy: Combined effects of tranexamic acid and licorice extract. Int J Pharm. 2021;600:120406.","journal-title":"Int J Pharm"},{"key":"287_CR25","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.2147\/CCID.S420501","volume":"16","author":"F Song","year":"2023","unstructured":"Song F, Wang Y, Wei XG, Yang N, Sun W, Li K, et al. Proteomic Analysis of Two Different Methods to Induce Skin Melanin Deposition Models in Guinea Pigs. Clin Cosmet Investig Dermatol. 2023;16:2341\u201356.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"Pt 2","key":"287_CR26","doi-asserted-by":"publisher","first-page":"132255","DOI":"10.1016\/j.ijbiomac.2024.132255","volume":"270","author":"C Zhang","year":"2024","unstructured":"Zhang C, Song X, Ma C, Wang M, Deng H, Yuan M, et al. Hyaluronic acid dissolving microneedle patch loaded with tranexamic acid for melasma treatment. Int J Biol Macromol. 2024;270(Pt 2):132255.","journal-title":"Int J Biol Macromol"},{"key":"287_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ejpb.2023.01.024","volume":"185","author":"YT He","year":"2023","unstructured":"He YT, Hao YY, Yu RX, Zhang C, Chen BZ, Cui Y, et al. Hydroquinone cream-based polymer microneedle roller for the combined treatment of large-area chloasma. Eur J Pharm Biopharm. 2023;185:5\u201312.","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"287_CR28","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/php.13189","volume":"96","author":"F Eltania","year":"2020","unstructured":"Eltania F, Lesmana R, Sudigdoadi S, Sudigdoadi S, Khairani AF, Goenawan H, et al. Tranexamic Acid Cream Protects Ultraviolet B-induced Photoaging in Balb\/c Mice Skin by Increasing Mitochondrial Markers: Changes Lead to Improvement of Histological Appearance. Photochem Photobiol. 2020;96(4):863\u20139.","journal-title":"Photochem Photobiol"},{"issue":"1","key":"287_CR29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3892\/mmr.2021.12522","volume":"25","author":"Y Bian","year":"2022","unstructured":"Bian Y, Yu H, Jin M, Gao X. Repigmentation by combined narrow-band ultraviolet B\/adipose-derived stem cell transplantation in the mouse model: Role of Nrf2\/HO-1-mediated Ca2+ homeostasis. Mol Med Rep. 2022;25(1):6.","journal-title":"Mol Med Rep"},{"issue":"1","key":"287_CR30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/pcmr.12911","volume":"34","author":"S Nakano","year":"2021","unstructured":"Nakano S, Abe Y, Nakajima K, Sano S, Yamamoto O, Wakamatsu K, et al. Establishment of a mouse model for post-inflammatory hyperpigmentation. Pigment Cell Melanoma Res. 2021;34(1):101\u201310.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"7","key":"287_CR31","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3390\/antiox8070207","volume":"8","author":"YJ You","year":"2019","unstructured":"You YJ, Wu PY, Liu YJ, Hou CW, Wu CS, Wen KC, et al. Sesamol Inhibited Ultraviolet Radiation-Induced Hyperpigmentation and Damage in C57BL\/6 Mouse Skin. Antioxid (Basel). 2019;8(7):207.","journal-title":"Antioxid (Basel)"},{"issue":"1","key":"287_CR32","doi-asserted-by":"publisher","first-page":"12874","DOI":"10.1038\/s41598-024-62828-z","volume":"14","author":"MJ Kim","year":"2024","unstructured":"Kim MJ, Ryu H, Jeong HH, Van JY, Hwang JY, Kim AR, et al. The beneficial effects of ethanolic extract of Sargassum serratifolium in DNCB-induced mouse model of atopic dermatitis. Sci Rep. 2024;14(1):12874.","journal-title":"Sci Rep"},{"issue":"2","key":"287_CR33","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s12247-025-09966-7","volume":"20","author":"U Khan","year":"2025","unstructured":"Khan U, Kumar P, Yasmin S, Durgapal S, Ashique S, Verma A. Preparation and Evaluation of N-Acetyl D-Glucosamine Ethosomal Gel for the Treatment of Hyperpigmentation. J Pharm Innov. 2025;20(2):52.","journal-title":"J Pharm Innov"},{"issue":"1","key":"287_CR34","doi-asserted-by":"publisher","first-page":"e13207","DOI":"10.1111\/pcmr.13207","volume":"38","author":"J Moon","year":"2025","unstructured":"Moon J, Moon IJ, Hyun H, Yoo JM, Bang SH, Song Y, et al. Bay 11-7082, an NF-\u03baB Inhibitor, Prevents Post-Inflammatory Hyperpigmentation Through Inhibition of Inflammation and Melanogenesis. Pigment Cell Melanoma Res. 2025;38(1):e13207.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"3","key":"287_CR35","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/pcmr.13162","volume":"37","author":"Y Wang","year":"2024","unstructured":"Wang Y, Herringshaw E, Anderson RR, Tam J. The Yucatan miniature swine as a model for post-inflammatory hyperpigmentation. Pigment Cell Melanoma Res. 2024;37(3):403\u201310.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"1","key":"287_CR36","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1002\/cpim.63","volume":"124","author":"RL Riding","year":"2019","unstructured":"Riding RL, Richmond JM, Harris JE. Mouse Model for Human Vitiligo. Curr Protoc Immunol. 2019;124(1):e63.","journal-title":"Curr Protoc Immunol"},{"issue":"223","key":"287_CR37","doi-asserted-by":"publisher","first-page":"223ra23","DOI":"10.1126\/scitranslmed.3007811","volume":"6","author":"M Rashighi","year":"2014","unstructured":"Rashighi M, Agarwal P, Richmond JM, Harris TH, Dresser K, Su MW, et al. CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo. Sci Transl Med. 2014;6(223):223ra23.","journal-title":"Sci Transl Med"},{"issue":"3","key":"287_CR38","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1021\/acsomega.4c09799","volume":"10","author":"Y Wei","year":"2025","unstructured":"Wei Y, Yu X, Zhao J, Gao M, Qiao M. Effective Components of Panax notoginseng-Salvia miltiorrhiza in the Treatment of Melasma and Its Experimental Study. ACS Omega. 2025;10(3):3033\u201343.","journal-title":"ACS Omega"}],"container-title":["Laboratory Animal Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42826-026-00287-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42826-026-00287-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42826-026-00287-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T09:38:39Z","timestamp":1784713119000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42826-026-00287-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["287"],"URL":"https:\/\/doi.org\/10.1186\/s42826-026-00287-5","relation":{},"ISSN":["2233-7660"],"issn-type":[{"value":"2233-7660","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not deal with humanistic ethics.","order":1,"name":"Ethics","label":"Human ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Morally approve and consent to participation.","order":2,"name":"Ethics","label":"Morality","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Agree to publish this article.","order":3,"name":"Ethics","label":"Issue a statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics.","order":4,"name":"Ethics","label":"The above picture design is from","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"27"}}